The Prostate Cancer Foundation (PCF) is the world's largest non-profit organization that funds patient-centric prostate cancer research. PCF has funded numerous critical studies surrounding the identification, biology, and clinical significance of prostate cancer germline and somatic genetic alterations, and is accelerating the application of these findings to improving outcomes for patients and their families.
You are browsing the legacy CJU website. The journal is now
published by Tech Science Press, and the latest issues, articles and
submission information are available on our new website.